Table 2.

Data analysis of Annexin/7-AAD cytofluorimetric apoptosis assays in OVCAR3 cells.

Samples	Early apoptosis (% ± SD)	Late apoptosis (% ± SD)	Live cells (% ± SD)
OVCAR3Neg Control NT∗	1.85 ± 0.64	6.55 ± 0.78	90.45 ± 1.77
OVCAR3Neg Control cisplatin (6 μM)∗∗	9.70 ± 0.57	6.80 ± 0.99	83.85 ± 1.20
OVCAR3Neg Control NAC (10 mM)	0.85 ± 0.79	6.35 ± 0.92	92.18 ± 1.77
OVCAR3Neg Control cisplatin (6 μM)/NAC (10 mM)	6.80 ± 0.42	4.15 ± 0.35	89.45 ± 0.92
OVCAR3siFHC	4.70 ± 0.14	12.15 ± 0.49	76.65 ± 1.06
OVCAR3siFHC cisplatin (6 μM)	45.65 ± 0.78	9.80 ± 1.13	43.85 ± 0.49

^∗OVCAR3^siFHC cisplatin (6 μM) vs. OVCAR3^{Neg Control} NT, p value < 0.05 (two-way ANOVA test). ^∗∗OVCAR3^siFHC cisplatin (6 μM) vs. OVCAR3^{Neg Control} cisplatin (6 μM), p value < 0.05 (two-way ANOVA test).